The acute phase response

NeuroImmune Biology

Volumn 3, Issue C, 2003, Pages 463-494

  Berczi, Istvan ^a,b   Szentivanyi, Andor ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60349094703     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(03)80059-5     Document Type: Article

References (219)

1. Nowotny A. In search of active sites in endotoxins. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 1-55
2. Boivin A., Mesrobeanu J., and Mesrobeanu L. Technique pour la preparation des polysaccharides microbiens specifiques. CR Soc Biol 113 (1933) 490
3. Favorite G.O., and Morgan H.R. Effects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella typhosa: Clinical, hematological, chemical and serological studies. J Clin Invest 21 (1942) 589
4. Greisman S.E. Induction of endotoxin tolerance. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 149-178
5. Behling U.H. The radioprotective effect of bacterial endotoxin. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 127-148
6. Parant M. Effect of LPS on nonspecific resistance to bacterial infections. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 179-196
7. Johnson A.G. Adjuvant action of bacterial endotoxins on antibody formation. A historical perspective. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 249-253
8. Butler R.C. Enhancement of nonspecific resistance to tumor by endotoxin. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 497-512
9. Walker R.I. Possibilities for use of endotoxin in compromised subjects. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 197-212
10. Abdelnoor A.M. Effect of LPS on the clotting system. In: Nowotny A. (Ed). Beneficial Effects of Endotoxins (1983), Plenum Press, New York 75-90
11. Pt 2. Cornell R.P. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration. Am J Physiol 249 5 (1985) R563-R569
12. Windle W.F., and Chambers W.W. Regeneration in spinal cord of cat and dog. J Comp Neurol 93 (1950) 241-258
13. Williams J.L., and Dick G.F. Decreased dextrose tolerance in acute infectious disease. Arch Intern Med 50 (1932) 801
14. Fox M.J., Kuzma J.F., and Washam W.T. Transitory diabetic syndromes associated with meningococcic meningitis. Arch Intern Med 79 (1947) 614
15. Beisel W.R. Metabolic response to infection. Ann Rev Med. 26 (1975) 9-20
16. Berczi I. The influence of pituitary-adrenal axis on the immune system. In: Berczi I. (Ed). Pituitary function and immunity (1986), CRC Press, Boca Raton, FL 49-132
17. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-I. Science 238 (1987) 524-526
18. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
19. Uehara A., Gottschall P.E., Dahl R.R., and Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 121 (1987) 1580-1582
20. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., and Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238 (1987) 519-521
21. Nakamura H., Motoyoshi S., and Kadokawa T. Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats. Eur J Pharmacol. 151 (1988) 67-73
22. Healy D.L., Hodgen G.D., Schulte H.M., Chrousos G.P., Loriaux D.L., Hall N.R., and Goldstein A.L. The thymus-adrenal connection: thymosin has corticotropin-releasing activity in primates. Science 222 (1983) 1353-1355
23. Selye H. A syndrome produced by diverse nocuous agents. Nature (1936) 32
24. Selye H. Thymus and the adrenals in response of the organism to injuries and intoxications. Br J Exp Pathol 17 (1936) 234-248
25. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol 6 (1946) 117-230
26. Selye H. Stress and disease. Science 122 (1955) 625
27. Selye H. Effect of ACTH and cortisone upon an "anaphylactoid reaction". Can Med Assoc J 61 (1949) 553-556
28. Karady S., Selye H., and Brownie J.S.L. The influence of the alarm reaction on the development of anaphylactic shock. J Immunol 35 (1938) 335
29. Selye H. Morphological changes in the fowl following chronic overdosage with various steroids. J Morphol 73 (1943) 401-421
30. Berczi I. Neurohormonal host defence in endotoxin shock. Ann NY Acad Sci 840 (1998) 787-802
31. Berczi I. The stress concept and neuroimmunoregulation in modern biology. Ann NY Acad Sci 851 (1998) 3-12
32. Haeryfar S.M.M., and Berczi I. The thymus and the acute phase response. Cell Mol Biol 47 (2001) 145-156
33. Berczi I., Bertok L., and Chow D. Natural immunity and neuroimmune host defence. Ann NY Acad Sci 917 (2001) 248-257
34. Berczi I., and Nagy E. Neurohormonal control of cytokines during injury. In: Rothwell N.J., and Berkenbosch F. (Eds). Brain Control of Responses to Trauma (1994), Cambridge University Press 32-107
35. O'Flaherty L., and Bouchier-Hayes D.J. Immunonutrition and surgical practice. Proc Nutr Soc 58 (1999) 831-837
36. Moses A.G., Dowidar N., Holloway B., Waddell I., Fearon K.C., and Ross J.A. Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients. Br J Surg 88 (2001) 588-593
37. Maruna P., Gurlich R., Fried M., Frasko R., Chachkhiani I., and Haluzik M. Leptin as an acute phase reactant after non-adjustable laparoscopic gastric banding. Obes Surg 11 (2001) 609-614
38. Barnetson S., and Gawkroger D. Hypersensitivy-type IV. In: Roitt I., Brostoff J., and Male D. (Eds). Immunology. 2nd edition 22 (1989), Gower Med Pub, London 1-22
39. Sinha A.A., Lopez M.T., and McDevitt H.O. Autoimmune disease. The failure of self tolerance. Science 248 (1990) 1380-1388
40. Eastman A., and Barry M.A. The origins of DNA breaks-A consequence of DNA damage, DNA repair, or apoptosis. Cancer Invest 10 (1992) 229-240
41. Hoshiya T., Watanabe D., Akagi K., Mizoguchi Y., Kamiya K., Mizuguchi H., Kumahara M., Toya H., Nagashima Y., and Okaniwa A. Acute phase response in toxicity studies. I. Survey of beagle dogs subjected to single-dose toxicity studies. J Toxicol Sci 26 (2001) 95-102
42. Banck G., and Forsgren A. Many bacterial species are mitogenic for human blood lymphocytes. Scand J Immunol 8 (1978) 347-354
43. Sibbald W.J., Short A., Chohen M.P., and Wilson R.F. Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterialinfections. Ann Surg 186 (1977) 29-33
44. Rothwell P.M., Udwadia Z.F., and Lawler P.G. Cortisol response to corticotropin and survival in septic shock. Lancet 337 (1991) 582-583
45. Curnow R.T., Rayfield E.J., George D.T., Zenser T.V., and De Rubertis E.R. Altered hepatic glycogen metabolism and glucoregulatory hormones during sepsis. Am J Physiol 230 (1976) 1296-1301
46. Iochida L.C., Tominaga M., Matsumoto M., Sekikawa A., and Sasaki H. Insulin resistance in septic rats-A study by the euglycemic clamp technique. Life Sci 45 (1989) 1567-1573
47. Lang C.H., and Dobrescu C. Sepsis-induced changes in in vivo insulin action in diabetic rats. Amer J Physiol 257 (1989) E301-E308
48. Lang C.H., and Dobrescu C. Gram-negative infection increases noninsulin-mediated glucose disposal. Endocrinology 128 (1991) 645-653
49. Leshin L.S., and Malven P.V. Bacteremia-induced changes in pituitary hormone release and effect of naloxone. Am J Physiol 247 (1984) E585-E591
50. Dahn M.S., Lange M.P., and Jacobs L.A. Insulinlike growth factor 1 production is inhibited in human sepsis. Arch Surg 123 (1988) 1409-1414
51. Westphal O., Jann K., and Himmelspach K. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy 33 (1983) 9-39
52. Ramachandra R.N., Berczi A., Sehon A.H., and Berczi I. Inhibition of lipid A and lipopolysaccharide (LPS) induced cytokine secretion, B cell mitogenesis and lethal shock by lipid A specific murinemonoclonal antibodies. J Infect Dis 167 (1993) 1151-1159
53. Berczi I. Neuroendocrine defence in endotoxin shock. (A review). Acta Microbiol Hung 40 (1993) 265-302
54. Raetz C.R.H., Ulevitch R.J., Wright S.D., Sibley C.H., Ding A., and Nathan C.F. Gram-negative endotoxin: An extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 5 (1991) 2652-2660
55. Tobias P.S., Mathison J., Mintz D., Lee J.D., Kravchenko V., Kato K., Pugin J., and Ulevitch R.J. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 7 (1992) 239-245
56. Schumann R.R. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 143 (1992) 11-15
57. Mathison J.C., Tobias P.S., Wolfson E., and Ulevitch R.J. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol 149 (1992) 200-206
58. Wright S.D., Ramos R.A., Patel M., and Miller D.S. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med 176 (1992) 719-727
59. Haziot A., Chen S., Ferrero E., Low M.G., Silber R., and Goyert S.M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141 (1988) 547-552
60. Kielian T.L., and Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 29 (1995) 187-205
61. Rivest S., Nadeau S., Lacroix S., and Laflamme N. Proinflammatory signal transduction pathways in the CNS during systemic immune response. In: Berczi I., and Gorczynski R.M. (Eds). New Foundation of Biology. Neuroimmune Biology, Volume I. Berczi I, Szentivanyi A, Series editors (2001), Elsevier 163-173
62. Berczi I., Bertok L., and Bereznay T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can J Microbiol 12 (1966) 1070-1071
63. Balm P.H., van Lieshout E., Lokate J., and Wendelaar Bonga S.E. Bacterial lipopolysaccharide (LPS) and interleukin 1 (IL-1) exert multiple physiological effects in the tilapia Oreochromis mossambicus (Teleostei). J Comp Physiol [B] 165 (1995) 85-92
64. Bang F.B. A bacterial disease of Limulus polyphemus. Bull Johns Hopkins Hosp 98 (1956) 325-351
65. Levin J., and Bang F.B. A description of cellular coagulation in the Limulus. Bull Johns Hopkins Hosp 115 (1964) 337-345
66. Levin J., and Bang F.B. The role of endotoxin in the extracellular coagulation of limulus blood. Bull Johns Hopkins Hosp 115 (1964) 265-274
67. Ramachandra R.N., Sehon A.H., and Berczi I. Neuro-hormonal host defence in endotoxin shock. Brain Behav Immun 6 (1992) 157-169
68. Parant M., Le Contel C., Parant F., and Chedid L. Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF-alpha. Lymphokine Cytokine Res. 10 (1991) 265-271
69. Zuckerman S.H., Shellhaas J., and Butler L.D. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19 (1989) 301-305
70. Richardson R.P., Rhyne C.D., Fong Y., Hesse D.G., Tracey K.J., Marano M.A., Lowry S.F., Antonacci A.C., and Calvano S.E. Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. Ann Surg 210 (1989) 239-245
71. Flohe S., Heinrich P.C., Schneider J., Wendel A., and Flohe L. Time course of IL-6 and TNF alpha release during endotoxin-induced endotoxin tolerance in rats. Biochem Pharmacol 41 (1991) 1607-1614
72. Barber A.E., Coyle S.M., Marano M.A., Fischer E., Calvano S.E., Fong Y., Moldawer L.L., and Lowry S.F. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150 (1993) 1999-2006
73. Waring P.M., Waring L.J., Billington T., and Metcalf D. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci U S A 92 (1995) 1337-1341
74. Granowitz E.V., Porat R., Mier J.W., Orencole S.F., Kaplanski G., Lynch E.A., Ye K., Vannier E., Wolff S.M., and Dinarello C.A. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151 (1993) 1637-1645
75. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G., and Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96 (1995) 2339-2347
76. Matic M., and Simon S.R. Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages. Infect Immun. 60 (1992) 3756-3762
77. Schade F.U., Franke C., Schlegel J., and Rietschel E.T. Formation of a TNF synthesis inhibitor in endotoxin tolerance. Prog Clin Biol Res. 392 (1995) 513-521
78. Henricson B.E., Neta R., and Vogel S.N. An interluekin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun. 59 (1991) 1188-1191
79. Berczi I., and Szentivanyi A. The pituitary gland, psychoneuroimmunology and infectious disease. In: Friedman H., Klein T., and Friedman A.L. (Eds). Psychoneuroimmunology, stress and infectious disease (1996), CRC Press, Boca Raton, FL 79-109
80. Wexler B.C., Dolgin A.E., and Tryczynski E.W. Effects of bacterial polysaccharide (Piromen) on the pituitary-adrenal axis: Adrenal ascorbic acid, cholesterol and histological alterations. Endocrinology 61 (1957) 300-308
81. Wilder R.L. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol. 13 (1995) 307-338
82. Torpy D.J., and Chrousos G.P. In: Chikanza I.C. (Ed). Neuroendocrine Immune Mechanisms of Rheumatic Diseases. Bailliere's Clin Rheumatol 10 (1996), Bailliere Tindall, London 181-198
83. Berczi I., Chalmers I.M., Nagy E., and Warrington R.J. The immune effects of neuropeptides. In: Chikanza I.C. (Ed). Neuroendocrine Immune Mechanisms of Rheumatic Diseases. Bailliere's Clin Rheumatol 10 (1996), Bailliere Tindall, London 227-257
84. Geller P., Merrill E.R., and Jawetz E. Effects of cortisone and antibiotics on lethal action of endotoxins in mice. Proc Soc Exp Biol Med 86 (1954) 716-719
85. Jansen N.J.G., Vanoeveren W., Hoiting B.H., and Wildevuur C.R.H. Methylprednisolone prophylaxis protects against endotoxin-induced death in rabbits. Inflammation 15 (1991) 91-101
86. Izumi T., and Bakhle Y.S. Modification by steroids of pulmonary oedema and prostaglandin E2 pharmacokinetics induced by endotoxin in rats. Brit J Pharmacol 93 (1988) 955-963
87. Sanchez-Cantu L., Rode H.N., Yun T.J., and Christou N.V. Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch Surg 126 (1991) 231-235
88. Ciancio M.J., Hunt J., Jones S.B., and Filkins J.P. Comparative and interactive in vivo effects of tumor necrosis factor and endotoxin. Circ Shock 33 (1991) 108-120
89. Mier J.W., Vachino G., Klempner M.S., Aronson F.R., Noring R., Smith S., Brandon E.P., Laird E.P., and Atkins M.B. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethansone-Prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood 76 (1990) 1933-1940
90. Sheppard B.C., Fraker D.L., and Norton J.A. Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factors. Surgery 106 (1989) 156-161
91. Paul W.E. The immune system: An introduction. In: Paul W.E. (Ed). Fundamental Immunology. 4th edition (1999), Lippincott-Raven, New York 1-18
92. Brostoff J., and Hall T. Hypersensitivity-Type I. In: Roitt I.M., Brostoff J., and Male D.K. (Eds). Immunology. 2nd edition 19 (1989), Gower Med Pub, London 1-19
93. Hay F. Hypersensitivity-Type III. In: Roitt I.M., Brostoff J., and Male D.K. (Eds). Immunology. 2nd edition 21 (1989), Gower Med Pub, London 1-21
94. In: Talal N. (Ed). Autoimmunity. Genetic, Immunologic, Virologic and Clinical Aspects (1977), Academic Press
95. Derijk R., and Berkenbosch F. The immune-hypothalamo-pituitary-adrenal axis and autoimmunity. Intern J Neuroscience 59 (1991) 91-100
96. Homo-Delarche F., Fitzpatrick F., Christeff N., Nunez E.A., Bach J.F., and Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 40 (1991) 619-637
97. Wannemacher Jr. R.W., Pekarek R.S., Thompson W.L., Curnow R.T., Beall F.A., Zenser T.V., deRubertis R.F., and Beisel W.R. A protein from polymorphonuclear leukocytes (LEM) which affects the rate of hepatic amino acid transport and synthesis of acute-phase globulins. Endocrinology 96 (1975) 651-661
98. Jamieson J.C., Lammers G., Janzen R., and Woloski B.M.R.N.J. The acute phase response to inflammation: The role of monokines in changes in liver glycoproteins and enzymes of glycoprotein metabolims. Comp Biochem Physiol 87B (1987) 11-15
99. Berczi I. Neurohormonal immunoregulation. Endocr Pathol 1 (1990) 197-219
100. Spangelo B.L., and Macleod R.M. Immunopeptide regulation of anterior pituitary function. Int J Neurosci. 51 (1990) 369-370
101. Akira S., and Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127 (1992) 26-50
102. Baue A.F. Neuroendocrine response to severe trauma and sepsis. In: Faist E., Ninnemann J., and Green D. (Eds). Immune consequences of trauma, shock and sepsis (1989), Springer Verlag 17-32
103. Bornstein S.R., Licinio J., Tauchnitz R., Engelmann L., Negrao A.B., Gold P., and Chrousos G.P. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83 (1998) 280-283
104. Giovambattista A., Chisari A.N., Corro L., Gaillard R.C., and Spinedi E. Metabolic, neuroendocrine and immune functions in basal conditions and during the acute-phase response to endotoxic shock in undernourished rats. Neuroimmunomodulation 7 (2000) 92-98
105. Okamoto S., Irie Y., Ishikawa I., Kimura K., and Masayuk S. Central leptin suppresses splenic lymphocyte functions through activation of the corticotropin-releasing hormone-sympathetic nervous system. Brain Res 855 (2000) 192-197
106. Chautard T., Spinedi E., Voirol M., Pralong F.P., and Gaillard R.C. Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administration. Neuroendocrinology 69 (1999) 360-369
107. Torpy D.J., Bornstein S.R., and Chrousos G.P. Leptin and interleukin-6 in sepsis. Horm Metab Res 30 (1998) 726-729
108. Faggioni R., Fantuzzi G., Gabay C., Moser A., Dinarello C.A., Feingold K.R., and Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276 (1999) R136-R142
109. Takahashi N., Waelput W., and Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189 (1999) 207-212
110. Finck B.N., Kelley K.W., Dantzer R., and Johnson R.W. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolsaccharide. Endocrinology 139 (1998) 2278-2283
111. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., Klein A.S., Bulkley G.B., Bao C., Noble P.W., Lane M.D., and Diehl A.M. Leptin regulates proinflammatory immune responses. FASEB J 12 (1998) 57-65
112. Fantuzzi G., and Faggioni R. Leptin in the regulation of immunity, inflammation, andhematopoiesis. J Leukoc Biol 68 (2000) 437-446
113. Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology. 183 (1991) 133-145
114. Ballou S.P., and Kushner I. C-reactive protein and the acute phase response. Adv Intern Med. 37 (1992) 313-336
115. Young B., Gleeson M., and Cripps A.W. C-reactive protein: a critical review. Pathology. 23 (1991) 118-124
116. Mold C., Nakayama S., Holzer T.J., Gewurz H., and Du Clos T.W. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med. 154 (1981) 1703-1708
117. Bauer J., Birmelin M., Northoff G.H., Northemann W., Tran-Thi T.A., Ueberberg H., Decker K., and Heinrich P. Induction of rat "2-macroglobulin in vivo and in heaptocyte primary cultures: synergistic action of glucocorticoids and a Kupffer cell derived factor. FEBS Lett 177 (1984) 89-94
118. van Gool J., Boers W., Sala M., and Ladiges N.C. Glucocorticoids and catecholamines as mediators of acute-phase proteins, especially rat alpha-macrofoetoprotein. Biochem J. 220 (1984) 125-132
119. Wassell J. Haptoglobin: function and polymorphism. Clin Lab 46 11-12 (2000) 547-552
120. Daemen M.A., Heemskerk V.H., van't Veer C., Denecker G., Wolfs T.G., Vandenabeele P., and Buurman W.A. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventingapoptosis and inflammation. Circulation 102 (2000) 1420-1426
121. Liu H., Jensen L., Hansen S., Petersen S.V., Takahashi K., Ezekowitz A.B., Hansen F.D., Jensenius J.C., and Thiel S. Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol 53 (2001) 489-497
122. Turner M.W., and Hamvas R.M. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2 (2000) 305-322
123. Van Gool J., Van Vugt H., Helle M., and Aarden L.A. The relation among stress, adrenalin, interleukin 6, and acute phase proteins in the rat. Clin Immunol Immunopathol 57 (1990) 200-210
124. Don B.R., Rosales L.M., Levine N.W., Mitch W., and Kaysen G.A. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 59 (2001) 1114-1120
125. Finck B.N., and Johnson R.W. Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech 50 (2000) 209-215
126. Haeryfar S.M., and Berczi I. The thymus and the acute phase response. Cell Mol Biol (Noisyle-grand) 47 (2001) 145-156
127. Bergad P.L., Schwarzenberg S.J., Humbert J.T., Morrison M., Amarasinghe S., Towle H.C., and Berry S.A. Inhibition of growth hormone action in models of inflammation. Am J Physiol Cell Physiol 279 6 (2000) C1906-C1917
128. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341 (1999) 785-792
129. Jaschke M.G., Herndon D.N., Wolf S.E., et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res 83 (1999) 122-129
130. Derfalvi B., Igaz P., Fulop K.A., Szalai C., and Falus A. Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone invitro. Cell Biol Int 24 (2000) 109-114
131. Berczi I., Nagy E., Asa S.L., and Kovacs K. Pituitary hormones and contact sensitivity in rats. Allergy 38 (1983) 325-330
132. Berczi I., Nagy E., Asa S.L., and Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum 27 (1984) 682-688
133. Ramirez R.J., Wolf S.E., and Herndon D.N. Is there a role for growth hormone in the clinical management of burn injuries?. Growth Horm IGF Res 8 Suppl B (1998) 99-105
134. Jeschke M.G., Barrow R.E., and Herndon D.N. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med 28 (2000) 1578-1584
135. Jeschke M.G., Herndon D.N., and Barrow R.E. Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann Surg 231 (2000) 408-416
136. Jeschke M.G., Herndon D.N., Wolf S.E., DebRoy M.A., Rai J., Thompson J.C., and Barrow R.E. Hepatocyte growth factor modulates the hepatic acute-phase response in thermally injured rats. Crit Care Med 28 (2000) 504-510
137. Jeschke M.G., Barrow R.E., and Herndon D.N. Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burnedchildren. Ann Surg 231 (2000) 246-252
138. Kvasnicka J., Marek J., Kvasnicka T., Weiss V., Markova M., Stepan J., and Umlaufova A. Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clin Endocrinol (Oxf) 52 (2000) 543-548
139. Hasday J.D., Fairchild K.D., and Shanholtz C. The role of fever in the infected host. Microbes Infect 2 (2000) 1891-1904
140. Krabbe K.S., Bruunsgaard H., Hansen C.M., Moller K., Fonsmark L., Qvist J., Madsen P.L., Kronborg G., Andersen H.O., Skinhoj P., and Pedersen B.K. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 8 (2001) 333-338
141. Kotler D.P. Cachexia. Ann Intern Med 133 (2000) 622-634
142. Langhans W. Anorexia of infection: current prospects. Nutrition 16 (2000) 996-1005
143. Oppert M., Gleiter C.H., Muller C., Reinicke A., von Ahsen N., Frei U., and Eckardt K.U. Kinetics and characteristics of an acute phase response following cardiac arrest. Intensive Care Med 25 (1999) 1386-1394
144. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
145. Kushner I. C-reactive protein elevation can be caused by conditions other than inflammationand may reflect biologic aging. Cleve Clin J Med 68 (2001) 535-537
146. Bruunsgaard H., Pedersen M., and Pedersen B.K. Aging and proinflammatory cytokines. Curr Opin Hematol 8 (2001) 131-136
147. Duncan B.B., and Schmidt M.I. Chronic activation of the innate immune system may underlie the metabolic syndrome. Sao Paulo Med 119 (2001) 122-127
148. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., and Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86 (2001) 1154-1159
149. Arnalich F., Hernanz A., Lopez-Maderuelo D., Pena J.M., Camacho J., Madero R., Vazquez J.J., and Montiel C. Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res 32 (2000) 407-412
150. Pickup J.C., Chusney G.D., Thomas S.M., and Burt D. Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 67 (2000) 291-300
151. Fernandez-Real J.M., Broch M., Vendrell J., Gutierrez C., Casamitjana R., Pugeat M., Richart C., and Ricart W. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49 (2000) 517-520
152. Pickup J.C., Chusney G.D., and Mattock M.B. The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction. Clin Endocrinol (Oxf) 52 (2000) 107-112
153. Lin R.Y., Trivino M.R., Curry A., Pesola G.R., Knight R.J., Lee H.S., Bakalchuk L., Tenenbaum C., and Westfal R.E. Interleukin 6 and C-reactive protein levels in patients with acute allergic reactions: an emergency department-based study. Ann Allergy Asthma Immunol 87 (2001) 412-416
154. Boss B., and Neeck G. Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis. Z Rheumatol 59 Suppl 2 (2000) 62-64
155. Sakane T., and Suzuki N. Neuro-endocrine-immune axis in human rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 48 (2000) 417-427
156. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., and Bresnihan B. Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res 2 (2000) 142-144
157. Janssen U., Bahlmann F., Kohl J., Zwirner J., Haubitz M., and Floege J. Activation of the acute phase response and complement C3 in patients with IgA nephropathy. Am J Kidney Dis 35 (2000) 21-28
158. Yang H., Wang H., and Tracey K.J. HMG-1 rediscovered as a cytokine. Shock 15 (2001) 247-253
159. Jamaluddin M., Meng T., Sun J., Boldogh I., Han Y., and Brasier A.R. Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation. Mol Endocrinol 14 (2000) 99-113
160. Cavaillon J.M. The nonspecific nature of endotoxin tolerance. Trends Microbiol. 3 (1995) 320-324
161. Mengozzi M., and Ghezzi P. Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Netw. 4 (1993) 89-98
162. Freudenberg M.A., and Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun. 56 (1988) 1352-1357
163. Evans G.F., and Zuckerman S.H. Glucocorticoid-dependent and-independent mechanisms involved in lipopolysaccharide tolerance. Eur J Immunol 21 (1991) 973-979
164. Szabo C., Thiemermann C., Wu C.C., Perretti M., and Vane J.R. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A 91 (1994) 271-275
165. Hansen M.K., Nguyen K.T., Goehler L.E., Gaykema R.P., Fleshner M., Maier S.F., and Watkins L.R. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton Neurosci 85 (2000) 119-126
166. Szalai A.J., van Ginkel F.W., Wang Y., McGhee J.R., and Volanakis J.E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component. J Immunol 165 (2000) 1030-1035
167. Galanos C., Freudenberg M.A., and Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 76 (1979) 5939-5943
168. Kimura T., Itoh N., Takehara M., Oguro I., Ishizaki J.I., Nakanishi T., and Tanaka K. Sensitivity of metallothionein-null mice to LPS/D-galactosamine-induced lethality. Biochem Biophys Res Commun 280 (2001) 358-362
169. Roth J., Hubschle T., Pehl U., Ross G., and Gerstberger R. Influence of systemic treatment with cyclooxygenase inhibitors on lipopolysaccharide-induced fever and circulating levels of cytokines and cortisol in guinea-pigs. Pflugers Arch 443 (2002) 411-417
170. Streetz K.L., Wustefeld T., Klein C., Manns M.P., and Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 47 (2001) 661-673
171. Shen X., Tian Z., Holtzman M.J., and Gao B. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism. Biochem J 352 Pt 3 (2000) 913-919
172. Jostock T., Mullberg J., Ozbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., and Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268 (2001) 160-167
173. Fennekohl A., Lucas M., and Puschel G.P. Induction by interleukin 6 of G(s)-coupled prostaglandin E(2) receptors in rat hepatocytes mediating a prostaglandin E(2)-dependent inhibition of thehepatocyte's acute phase response. Hepatology 31 (2000) 1128-1134
174. Beigneux A.P., Moser A.H., Shigenaga J.K., Grunfeld C., and Feingold K.R. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275 (2000) 16390-16399
175. Harris H.W., Gosnell J.E., and Kumwenda Z.L. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 6 (2000) 421-430
176. Fulop A.K., Pocsik E., Brozik M., Karabelyos C., Kiss A., Novak I., Szalai C., Dobozy O., and Falus A. Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors. Cell Biol Int 25 (2001) 585-592
177. Hecht N., Pappo O., Shouval D., Rose-John S., Galun E., and Axelrod J.H. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol Ther 3 5 Pt 1 (2001) 683-687
178. Gabay C., Gigley J., Sipe J., Arend W.P., and Fantuzzi G. Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur J Immunol 31 (2001) 490-499
179. Carstanjen D., Regenfus M., Muller C., and Salama A. Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp Hematol 29 (2001) 812-821
180. Suwa T., Hogg J.C., Klut M.E., Hards J., and van Eeden S.F. Interleukin-6 changes deformability of neutrophils and induces their sequestration in the lung. Am J Respir Crit Care Med 163 (2001) 970-976
181. Beishuizen A., Thijs L.G., Haanen C., and Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 86 (2001) 2811-2816
182. Seatter S.C., Bennet T., Li M.H., Bubrick M.P., and West M.A. Macrophage endotoxin tolerance. Tumor necrosis factor and interleukin-1 regulation by lipopolysaccharide pretreatment. Arch. Surg. 129 (1994) 1263-1269
183. Li M.H., Seatter S.C., Manthei R., Bubrick M., and West M.A. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res. 57 (1994) 85-92
184. Previte J.J., Chang Y., and El-Bisi H.M. Detoxification of Salmonella typhimurium lipopolysaccharide by ionizing radiation. J Bacteriol 93 (1967) 1607
185. Fust G., Bertok L., and Juhasz-Nagy S. Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system. Infect Immun. 16 (1977) 26-31
186. Bertok L. Stimulation of nonspecific resistance by radiation-detoxified endotoxin. In: Nowotny A. (Ed). Beneficial Effects of Endotoxin (1983), Plenum Press, New York 213-226
187. Banhegyi D., Varnai F., Horvath A., and Bertok L. Treatment of severe immune deficiency with radio-detoxified endotoxin. J Med. 23 (1992) 154-156
188. Gustafson G.L., Rhodes M.J., and Hegel T. Monophosphoryl lipid A as a prophylactic for sepsis and septic shock. Prog Clin Biol Res. 392 (1995) 567-579
189. Astiz M.E., Rackow E.C., Still J.G., Howell S.T., Cato A., Von Eschen K.B., Ulrich J.T., Rudbach J.A., McMahon G., Vargas R., et al. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med. 23 (1995) 9-17
190. Anisman H., Baines M.G., Berczi I., et al. Neuroimmune mechanisms in health and disease: 1. Health. Can Med Assoc J 155 (1996) 867-874
191. Anisman H., Baines M.G., Berczi I., et al. Neuroimmune mechanisms in health and disease: 2. Disease. Can Med Assoc J 155 (1996) 1075-1082
192. Berczi I., Chow D.A., and Sabbadini E.R. Neuroimmunoregulation and Natural Immunity. Domestic Anim Endocrin 15 (1998) 273-281
193. Somech R., Zakuth V., Assia A., Jurgenson U., and Spirer Z. Procalcitonin correlates with C-reactive protein as an acute-phase reactant in pediatric patients. Isr Med Assoc J 2 (2000) 147-150
194. Stephensen C.B., and Gildengorin G. Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 72 (2000) 1170-1178
195. Zweigner J., Gramm H.J., Singer O.C., Wegscheider K., and Schumann R.R. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98 (2001) 3800-3808
196. Schmid B., Wong S., and Mitchell B.F. Transcriptional regulation of oxytocin receptor by interleukin-1beta and interleukin-6. Endocrinology 142 (2001) 1380-1385
197. Marchini G., Berggren V., Djilali-Merzoug R., and Hansson L.O. The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Paediatr 89 (2000) 1082-1086
198. Pedersen B.K. Special feature for the Olympics: effects of exercise on the immune system: exercise and cytokines. Immunol Cell Biol 78 (2000) 532-535
199. Pedersen B.K., and Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80 (2000) 1055-1081
200. Jeukendrup A.E., Vet-Joop K., Sturk A., Stegen J.H., Senden J., Saris W.H., and Wagenmakers A.J. Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci (Lond) 98 (2000) 47-55
201. Luyer M.D., Khosla S., Owen W.G., and Miller V.M. Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women. J Clin Endocrinol Metab 86 (2001) 3629-3634
202. Hak A.E., Pols H.A., Stehouwer C.D., Meijer J., Kiliaan A.J., Hofman A., Breteler M.M., and Witteman J.C. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86 (2001) 4398
203. Banck G., and Forsgren A. Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol. 8 (1978) 347-354
204. Fleischer B., Gerlach D., Fuhrmann A., and Schmidt K.H. Superantigens and pseudosuperantigens of gram-positive cocci. Med Microbiol Immunol (Berl) 184 (1995) 1-8
205. Levinson A.I., Kozlowski L., Zheng Y., and Wheatley L. B-cell superantigens: definition and potential impact on the immune response. J Clin Immunol 15 6 Suppl (1995) 26S-36S
206. Zumla A. Superantigens, T cells and microbes. Clin Infect Dis 15 (1992) 313-320
207. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev. 8 (1995) 411-426
208. Spangelo B.L., deHoll P.D., Kalabay L., Bond B.R., and Arnaud P. Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: effects of lipopolysaccharide and interleukin-1 beta. Endocrinology 135 (1994) 556-563
209. Chao H.S., Poisner A.M., Poisner R., and Handwerger S. Lipopolysaccharides inhibit prolactin and renin release from human decidual cells. Biol Reprod. 50 (1994) 210-214
210. Di Santo E., Sironi M., Pozzi P., Gnocchi P., Isetta A.M., Delvaux A., Goldman M., Marchant A., and Ghezzi P. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting theactivation of the hypothalamus-pituitary-adrenal axis. Neuroimmunomodulation 2 (1995) 149-154
211. Faggioni R., Fantuzzi G., Villa P., Buurman W., van Tits L.J., and Ghezzi P. Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun. 63 (1995) 1473-1477
212. Das K.P., McMillian M.K., Bing G., and Hong J.S. Modulatory effects of [Met5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures. J Neuroimmunol 62 (1995) 9-17
213. Scotte M., Hiron M., Masson S., Lyoumi S., Banine F., Teniere P., Lebreton J.P., and Daveau M. Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver following endotoxin- or turpentine-induced inflammation inrat. Cytokine 8 (1996) 115-120
214. Gaykema R.P., Dijkstra I., and Tilders F.J. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 136 (1995) 4717-4720
215. Pt 2. Laye S., Bluthe R.M., Kent S., Combe C., Medina C., Parnet P., Kelley K., and Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol. 268 5 (1995) R1327-R1331
216. Berczi I., Bertok L., Baintner Jr. K., and Veress B. Failure of oral Escherichia coli endotoxin to induce either specific tolerance or toxic syndromes in rats. J Path Bact 96 (1968) 481-486
217. Kocsar L.T., Bertok L., and Varteresz V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol. 100 (1969) 220-223
218. Mimura Y., Sakisaka S., Harada M., Sata M., and Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 109 (1995) 1969-1976
219. Bertok L. Physico-chemical defence of vertebrate organisms: the role of bile acids in defence against endotoxins. Persp Biol Med 21 (1977) 70-76